
The demand for self-monitoring blood glucose systems from the end-user industry is growing as a larger number of people suffer from diabetes mellitus. Improvement in portable smart glucose devices and ease of use with smart glucose devices is driving the global market during the forecast period. Diabetes educators are teaching an ever-increasing number of people with diabetes to use Smart Monitoring Blood Glucose to increase the life span of patients and try to maintain their sugar level by regular monitoring.
The global market for Smart Glucose Device was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Smart Glucose Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Smart Glucose Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Smart Glucose Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Smart Glucose Device include Medtronic, F. Hoffmann-La Roche Ltd., Bayer AG, Dexcom, Inc., B Braun Melsungen AG., Lifescan, Inc., Sanofi and Elly Lilly, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Smart Glucose Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Smart Glucose Device by region & country, by Type, and by Application.
The Smart Glucose Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Smart Glucose Device.
Market Segmentation
By Company
Medtronic
F. Hoffmann-La Roche Ltd.
Bayer AG
Dexcom, Inc.
B Braun Melsungen AG.
Lifescan, Inc.
Sanofi
Elly Lilly
Segment by Type:
Continuous Glucose Monitoring Devices
Self-Monitoring Blood Glucose Systems
Segment by Application
Hospitals
Home Care
Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Smart Glucose Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Smart Glucose Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Smart Glucose Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Smart Glucose Device Product Introduction
1.2 Global Smart Glucose Device Market Size Forecast
1.2.1 Global Smart Glucose Device Sales Value (2019-2030)
1.2.2 Global Smart Glucose Device Sales Volume (2019-2030)
1.2.3 Global Smart Glucose Device Sales Price (2019-2030)
1.3 Smart Glucose Device Market Trends & Drivers
1.3.1 Smart Glucose Device Industry Trends
1.3.2 Smart Glucose Device Market Drivers & Opportunity
1.3.3 Smart Glucose Device Market Challenges
1.3.4 Smart Glucose Device Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Smart Glucose Device Players Revenue Ranking (2023)
2.2 Global Smart Glucose Device Revenue by Company (2019-2024)
2.3 Global Smart Glucose Device Players Sales Volume Ranking (2023)
2.4 Global Smart Glucose Device Sales Volume by Company Players (2019-2024)
2.5 Global Smart Glucose Device Average Price by Company (2019-2024)
2.6 Key Manufacturers Smart Glucose Device Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Smart Glucose Device Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Smart Glucose Device
2.9 Smart Glucose Device Market Competitive Analysis
2.9.1 Smart Glucose Device Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Smart Glucose Device Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Smart Glucose Device as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Continuous Glucose Monitoring Devices
3.1.2 Self-Monitoring Blood Glucose Systems
3.2 Global Smart Glucose Device Sales Value by Type
3.2.1 Global Smart Glucose Device Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Smart Glucose Device Sales Value, by Type (2019-2030)
3.2.3 Global Smart Glucose Device Sales Value, by Type (%) (2019-2030)
3.3 Global Smart Glucose Device Sales Volume by Type
3.3.1 Global Smart Glucose Device Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Smart Glucose Device Sales Volume, by Type (2019-2030)
3.3.3 Global Smart Glucose Device Sales Volume, by Type (%) (2019-2030)
3.4 Global Smart Glucose Device Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Home Care
4.1.3 Diagnostic Centers
4.2 Global Smart Glucose Device Sales Value by Application
4.2.1 Global Smart Glucose Device Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Smart Glucose Device Sales Value, by Application (2019-2030)
4.2.3 Global Smart Glucose Device Sales Value, by Application (%) (2019-2030)
4.3 Global Smart Glucose Device Sales Volume by Application
4.3.1 Global Smart Glucose Device Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Smart Glucose Device Sales Volume, by Application (2019-2030)
4.3.3 Global Smart Glucose Device Sales Volume, by Application (%) (2019-2030)
4.4 Global Smart Glucose Device Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Smart Glucose Device Sales Value by Region
5.1.1 Global Smart Glucose Device Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Smart Glucose Device Sales Value by Region (2019-2024)
5.1.3 Global Smart Glucose Device Sales Value by Region (2025-2030)
5.1.4 Global Smart Glucose Device Sales Value by Region (%), (2019-2030)
5.2 Global Smart Glucose Device Sales Volume by Region
5.2.1 Global Smart Glucose Device Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Smart Glucose Device Sales Volume by Region (2019-2024)
5.2.3 Global Smart Glucose Device Sales Volume by Region (2025-2030)
5.2.4 Global Smart Glucose Device Sales Volume by Region (%), (2019-2030)
5.3 Global Smart Glucose Device Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Smart Glucose Device Sales Value, 2019-2030
5.4.2 North America Smart Glucose Device Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Smart Glucose Device Sales Value, 2019-2030
5.5.2 Europe Smart Glucose Device Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Smart Glucose Device Sales Value, 2019-2030
5.6.2 Asia Pacific Smart Glucose Device Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Smart Glucose Device Sales Value, 2019-2030
5.7.2 South America Smart Glucose Device Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Smart Glucose Device Sales Value, 2019-2030
5.8.2 Middle East & Africa Smart Glucose Device Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Smart Glucose Device Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Smart Glucose Device Sales Value
6.2.1 Key Countries/Regions Smart Glucose Device Sales Value, 2019-2030
6.2.2 Key Countries/Regions Smart Glucose Device Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Smart Glucose Device Sales Value, 2019-2030
6.3.2 United States Smart Glucose Device Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Smart Glucose Device Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Smart Glucose Device Sales Value, 2019-2030
6.4.2 Europe Smart Glucose Device Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Smart Glucose Device Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Smart Glucose Device Sales Value, 2019-2030
6.5.2 China Smart Glucose Device Sales Value by Type (%), 2023 VS 2030
6.5.3 China Smart Glucose Device Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Smart Glucose Device Sales Value, 2019-2030
6.6.2 Japan Smart Glucose Device Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Smart Glucose Device Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Smart Glucose Device Sales Value, 2019-2030
6.7.2 South Korea Smart Glucose Device Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Smart Glucose Device Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Smart Glucose Device Sales Value, 2019-2030
6.8.2 Southeast Asia Smart Glucose Device Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Smart Glucose Device Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Smart Glucose Device Sales Value, 2019-2030
6.9.2 India Smart Glucose Device Sales Value by Type (%), 2023 VS 2030
6.9.3 India Smart Glucose Device Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Company Information
7.1.2 Medtronic Introduction and Business Overview
7.1.3 Medtronic Smart Glucose Device Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Medtronic Smart Glucose Device Product Offerings
7.1.5 Medtronic Recent Development
7.2 F. Hoffmann-La Roche Ltd.
7.2.1 F. Hoffmann-La Roche Ltd. Company Information
7.2.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
7.2.3 F. Hoffmann-La Roche Ltd. Smart Glucose Device Sales, Revenue and Gross Margin (2019-2024)
7.2.4 F. Hoffmann-La Roche Ltd. Smart Glucose Device Product Offerings
7.2.5 F. Hoffmann-La Roche Ltd. Recent Development
7.3 Bayer AG
7.3.1 Bayer AG Company Information
7.3.2 Bayer AG Introduction and Business Overview
7.3.3 Bayer AG Smart Glucose Device Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Bayer AG Smart Glucose Device Product Offerings
7.3.5 Bayer AG Recent Development
7.4 Dexcom, Inc.
7.4.1 Dexcom, Inc. Company Information
7.4.2 Dexcom, Inc. Introduction and Business Overview
7.4.3 Dexcom, Inc. Smart Glucose Device Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Dexcom, Inc. Smart Glucose Device Product Offerings
7.4.5 Dexcom, Inc. Recent Development
7.5 B Braun Melsungen AG.
7.5.1 B Braun Melsungen AG. Company Information
7.5.2 B Braun Melsungen AG. Introduction and Business Overview
7.5.3 B Braun Melsungen AG. Smart Glucose Device Sales, Revenue and Gross Margin (2019-2024)
7.5.4 B Braun Melsungen AG. Smart Glucose Device Product Offerings
7.5.5 B Braun Melsungen AG. Recent Development
7.6 Lifescan, Inc.
7.6.1 Lifescan, Inc. Company Information
7.6.2 Lifescan, Inc. Introduction and Business Overview
7.6.3 Lifescan, Inc. Smart Glucose Device Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Lifescan, Inc. Smart Glucose Device Product Offerings
7.6.5 Lifescan, Inc. Recent Development
7.7 Sanofi
7.7.1 Sanofi Company Information
7.7.2 Sanofi Introduction and Business Overview
7.7.3 Sanofi Smart Glucose Device Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Sanofi Smart Glucose Device Product Offerings
7.7.5 Sanofi Recent Development
7.8 Elly Lilly
7.8.1 Elly Lilly Company Information
7.8.2 Elly Lilly Introduction and Business Overview
7.8.3 Elly Lilly Smart Glucose Device Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Elly Lilly Smart Glucose Device Product Offerings
7.8.5 Elly Lilly Recent Development
8 Industry Chain Analysis
8.1 Smart Glucose Device Industrial Chain
8.2 Smart Glucose Device Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Smart Glucose Device Sales Model
8.5.2 Sales Channel
8.5.3 Smart Glucose Device Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Medtronic
F. Hoffmann-La Roche Ltd.
Bayer AG
Dexcom, Inc.
B Braun Melsungen AG.
Lifescan, Inc.
Sanofi
Elly Lilly
Ìý
Ìý
*If Applicable.
